The p38a MAPK positively regulates osteoblast function and postnatal bone acquisition

Cellular and Molecular Life Sciences

Volumn 69, Issue 18, 2012, Pages 3115-3125

  Thouverey, Cyril ^a   Caverzasio, Joseph ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bone formation; Osteoblast; p38a MAPK; Postnatal

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCALCIN; OSTEOPONTIN; ALKALINE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 14; SPP1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE REMODELING; CELL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; AGE; ANIMAL; BONE DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; NEWBORN; OSTEOLYSIS; PHYSIOLOGY;

MUS;

AGE FACTORS; ALKALINE PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; COLLAGEN TYPE I; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 14; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN;

EID: 84865628977     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-0983-8     Document Type: Article

References (38)

1. Raggatt LJ, Partridge NC (2010) Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285:25103-25108
2. Zarubin T, Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15:11-18 (Pubitemid 41653958)
3. Cuadrado A, Nebreda AR (2010) Mechanisms and functions of p38 MAPK signaling. Biochem J 429:403-417
4. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J (2003) Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 18:2060-2068 (Pubitemid 37377457)
5. Lee KS, Hong SH, Bae SC (2002) Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21:7156-7163
6. Suzuki A, Palmer G, Bonjour JP, Caverzasio J (1999) Regulation of alkaline phosphatase activity by p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology 140:3177-3182 (Pubitemid 30650634)
7. Rey A, Manen D, Rizzoli R, Ferrari SL, Caverzasio J (2007) Evidences for a role of p38 MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells. Bone 41:59-67 (Pubitemid 46891895)
8. Caverzasio J, Manen D (2007) Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells. Endocrinology 148:5323-5330 (Pubitemid 350012642)
9. You J, Reilly GC, Zhen X, Yellowley CE, Chen Q, Donahue HJ, Jacobs CR (2001) Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts. J Biol Chem 276:13365-13371
10. Ulsamer A, Ortuño MJ, Ruiz S, Susperregui AR, Osses N, Rosa JL, Ventura F (2008) BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem 283:3816-3826
11. Ortuno MJ, Ruiz-Gaspa S, Rodriguez-Carballo E, Susperregui AR, Bartrons R, Rosa JL, Ventura F (2010) p38 regulates expression of osteoblast-specific genes by phosphorylation of Osterix. J Biol Chem 285:31985-31994
12. Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM, Arthur S, Xie M, Schneider MD, Zhai B, Gygi S, Davis R, Glimcher LH (2010) The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest 120:2457-2473
13. Zou W, Greenblatt MB, Shim JH, Kant S, Zhai B, Lotinun S, Brady N, Hu DZ, Gygi SP, Baron R, Davis RJ, Jones D, Glimcher LH (2011) MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice. J Clin Invest 121:4383-4392
14. Whitehouse CA, Waters S, Marchbank K, Horner A, McGowan NW, Jovanovic JV, Xavier GM, Kashima TG, Cobourne MT, Richards GO, Sharpe PT, Skerry TM, Grigoriadis AE, Solomon E (2010) Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity. Proc Natl Acad Sci USA 107:12913-12918
15. Heinrichsdorff J, Luedde T, Perdiguero E, Nebreda AR, Pasparakis M (2008) p38alpha MAPK inhibits JNK activation and collaborates with IkappaB kinase 2 to prevent endotoxin-induced liver failure. EMBO Rep 9:1048-1054
16. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL (2002) Osteoblast-specific knockout of the insulinlike growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012 (Pubitemid 36157826)
17. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR (2000) Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6:109-116
18. Bonnet N, Standley KN, Bianchi EN, Stadelmann V, Foti M, Conway SJ, Ferrari SL (2009) The matricellular protein periostin is required for SOST inhibition and the anabolic response to mechanical loading and physical activity. J Biol Chem 284:35939-35950
19. Zhu H, Guo ZK, Jiang XX, Li H, Wang XY, Yao HY, Zhang Y, Mao N (2010) A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 5:550-560
20. Canalis E (2010) Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 95:1496-1504
21. Trivedi R, Goswami R, Chattopadhyay N (2010) Investigational anabolic therapies for osteoporosis. Expert Opin Investig Drugs 19:995-1005
22. Marie PJ, Kassem M (2011) Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol 165:1-10
23. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G (1999) A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:1025-1036 (Pubitemid 29200985)
24. Baek WY, Lee MA, Jung JW, Kim SY, Akiyama H, de Crombrugghe B, Kim JE (2009) Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J Bone Miner Res 24:1055-1065
25. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117:387-398 (Pubitemid 38534544)
26. Mak KK, Bi Y, Wan C, Chuang PT, Clemens T, Young M, Yang Y (2008) Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression. Dev Cell 14:674-688 (Pubitemid 351622607)
27. Baron R, Rawadi G, Roman-Roman S (2006) Wnt signaling: a key regulator of bone mass. Curr Top Dev Biol 76:103-127 (Pubitemid 44760540)
28. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, Mundy GR, Chen D (2002) Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol 157:1049-1060 (Pubitemid 34839779)
29. Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, Noda T, Yamamoto T (2000) Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103:1085-1097 (Pubitemid 32037395)
30. Tan X, Weng T, Zhang J, Wang J, Li W, Wan H, Lan Y, Cheng X, Hou N, Liu H, Ding J, Lin F, Yang R, Gao X, Chen D, Yang X (2007) Smad4 is required for maintaining normal murine postnatal bone homeostasis. J Cell Sci 120:2162-2170 (Pubitemid 47074122)
31. Yamashita M, Ying SX, Zhang GM, Li C, Cheng SY, Deng CX, Zhang YE (2005) Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 121:101-113
32. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317 (Pubitemid 35345151)
33. Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, Faugere MC, Aja S, Hussain MA, Brüning JC, Clemens TL (2010) Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142:309-319
34. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, Ejiri S, Tanaka M, Izumi N, Ozawa H, Goltzman D (1996) Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 175:166-176 (Pubitemid 26148780)
35. Richman C, Kutilek S, Miyakoshi N, Srivastava AK, Beamer WG, Donahue LR, Rosen CJ, Wergedal JE, Baylink DJ, Mohan S (2001) Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/ HeJ and C57BL/6J mice. J Bone Miner Res 16:386-397 (Pubitemid 32105420)
36. Schieven GL (2009) The p38alpha kinase plays a central role in inflammation. Curr Top Med Chem 9:1038-1048
37. Mbalaviele G, Anderson G, Jones A,De Ciechi P, Settle S,Mnich S, Thiede M, Abu-Amer Y, Portanova J, Monahan J (2006) Inhibition of p38mitogen-activated protein kinase prevents inflammatory bone destruction. J Pharmacol Exp Ther 317:1044-1053 (Pubitemid 43764107)
38. Caverzasio J, Higgins L, Ammann P (2008) Prevention of trabecular bone loss induced by estrogen deficiency by a selective p38alpha inhibitor. J Bone Miner Res 23:1389-1397